| Mucinous Cystadenocarcinoma studied in …STUDIED_INderived22 of 22show fewer |
|---|
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01081262Phase 3 · active not recruiting Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02111941early Phase 1 · completed Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01074411Phase 1 · completed Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00993616Phase 2 · completed Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079430Phase 1 · completed Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085358Phase 1 · completed Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357448Phase 1 · completed Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939809Phase 2 · completed A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01275664NA · terminated Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01080521completed Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00466960Phase 2 · completed Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004221Phase 2 · terminated Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00059787Phase 2 · completed Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060359Phase 1 · completed Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00814086Phase 1 · completed Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01492920Phase 3 · withdrawn Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294293Phase 1 · completed TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01233505Phase 1 · terminated Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002913Phase 1 · completed Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 22 trials mapped (4 active) | — | — | Ovarian Mucinous Cystadenocarcinoma | 1 | Observed | clinicaltrials | graph → |